startupticker.ch4d
Start-up boom thriving at ETH Zurich
With 37 new spin-offs, ETH Zurich continues its long-term upward trend in the launch of new companies from its research.
Basilea Pharmaceutica AG: Strong sales growth for Cresemba and Zevtera trigger further milestone payments to Basilea
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...
Strong sales growth for Cresemba and Zevtera trigger further milestone payments to Basilea
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...
SKAN announces preliminary key figures for the 2024 financial year
SKAN AG / Key word (s): Preliminary Results SKAN announces preliminary key figures for the 2024 financial year 22-Jan-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The ...
The Lancet24d
Beyond repellents: spatial emanators for the control of malaria in Africa
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Spatial repellents have ...
Business Wire1mon
Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera ® (ceftobiprole)
Allschwil (SIX: BSLN), for the commercialization of Zevtera ® (ceftobiprole), an advanced-generation cephalosporin antibiotic, in the United States. "The licensing of Zevtera expands IST’s ...